Ninepoint Enhanced Canadian HighShares Fund - Series A

Ninepoint Enhanced Canadian HighShares Fund
  • Daily NAV Change · As at 7/8/2026
    -$0.08 (-0.87%)
  • NAV · As at 7/8/2026
    $9.28
  • Risk Tolerance
    Medium
  • Distributions††
    $0.1550 Monthly
  • Inception Date
    3/27/2017

Overview

One trade. Complete income solution.

The Ninepoint Enhanced Canadian HighShares wrapper provides exposure to leverage through its underlying funds, along with covered calls, blue-chip exposure, and tax efficiency — all in a single fund. With one trade, investors access a fully diversified, high-income strategy designed for simplicity, transparency, and ease of use.

Why invest in Enhanced Canadian HighShares?

Lower Fee
At 0.30% (Series F) and 1.30% (Series A), Ninepoint HighShares is one of the lowest‑cost Canadian single‑stock covered call funds — helping reduce cost drag on compounded monthly income.

Active Management
Covered calls demand daily, active decisions that directly influence income and total return.

Institutional Experience
Every option is managed with the same discipline Ninepoint applies across $8+ billion in high net-worth and institutional mandates.

Built-In Tax Efficiency
The Fund has approximately $23.7 million in capital loss carryforwards as at June 30, 2026, which may help offset future realized capital gains and support improved after-tax outcomes for taxable investors.*

*Capital loss carryforwards may be used to offset future realized capital gains. There is no guarantee that the Fund will realize capital gains in the future or that capital loss carryforwards will result in tax savings for investors. Tax treatment depends on an investor’s individual circumstances and may change over time.

Fund Objective

The investment objective of the Fund is to seek to provide securityholders with high monthly cash distributions and the opportunity for capital appreciation by investing primarily in a portfolio of exchange traded mutual funds managed by the Manager that (i) invest in single equity securities, and (ii) engage in covered call strategies.

Investment Team

  • John Wilson, MBA
    Co-CEO, Managing Partner, Senior Portfolio Manager
    John Wilson, MBA
    Co-CEO, Managing Partner, Senior Portfolio Manager
    John Wilson is a founding principal, Co-CEO and Managing Partner of Ninepoint Partners. John oversees all aspects of the firm’s investment and research initiatives. Prior to Ninepoint’s formation, he was CEO, CO-CIO and Senior Portfolio Manager at Sprott Asset Management (SAM). Previous to SAM, he was Chief Investment Officer at Cumberland Private Wealth Management, founder and CEO of DDX Capital Partners, an alternative investment management firm; was Managing Director at RBC Capital Markets...
    View Full Bio
  • Colin Watson
    Portfolio Manager; Head of Derivatives Strategies
    Colin Watson
    Portfolio Manager; Head of Derivatives Strategies
    Colin Watson's background spans across equities, asset allocation & derivative-based strategies. Prior to Ninepoint Partners, Colin worked as a Portfolio Manager at IMCO on a team responsible for overseeing IMCO’s $26B public equity allocation and deploying derivatives-based strategies for IMCO’s public asset allocation strategy. Prior to IMCO, Colin worked at Ninepoint Partners on equity selection & options-based overlays. Colin holds a Bachelor of Commerce Degree from McMaster Unive...
    View Full Bio
  • Zach Chen, CFA
    Senior Analyst, Derivatives Strategies
    Zach Chen, CFA
    Senior Analyst, Derivatives Strategies
    Zach Chen is an Analyst on the Ninepoint HighShares ETFs and the Ninepoint Energy Income Fund where he assists with the equity option overlay. He is also an analyst on the Ninepoint Global Infrastructure Fund, where he researches infrastructure related equities. Prior to Ninepoint Zach interned in Investment Banking M&A at ATB Capital Markets. Zach graduated from Ivey Business School (HBA) and also holds a Bachelor of Engineering Science in Mechatronic Systems Engineering from Wester...
    View Full Bio

Series A Performance

Compound Returns

As at 6/30/2026 (Series A) NPP5420
Compound Returns
MTD % YTD % 1Y % 3Y % 5Y % 10Y % Inception %
-0.44
As at 7/8/2026
-1.06 18.55 -3.72 -16.49 - -0.32
Inception Date: March 27, 2017.

Effective July 8, 2026 Ninepoint Cannabis & Alternative Health Fund changed its name to Ninepoint Enhanced Canadian HighShares Fund; and changed its investment strategies to invest primarily in a portfolio of exchange-traded funds that invest in single equity securities and employ covered call strategies, with the aim of providing high monthly cash distributions and the opportunity for capital appreciation.

The above is the performance for the Ninepoint Cannabis & Alternative Health Fund up to July 8, 2026. All performance after July 8, 2026 is that of the Ninepoint Enhanced Canadian HighShares Fund.

Monthly Returns (%)

As at 5/29/2026 (Series A) NPP5420
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2026 -7.04 0.38 -1.34 6.88 -1.06 -2.65
2025 -2.22 -0.58 -8.85 1.79 -4.85 -1.55 2.04 17.23 -1.42 -3.85 -4.25 10.37 1.23
2024 14.71 -0.39 7.93 4.27 -16.39 -2.29 1.31 -8.81 6.29 -2.50 -12.36 -5.42 -16.65
2023 -3.66 -1.79 -3.79 1.54 -4.44 -0.55 -1.99 9.74 1.44 -9.16 7.40 0.43 -6.09
2022 -12.51 1.00 -0.57 -10.94 -4.22 -9.11 2.40 3.97 -9.07 9.32 1.41 -14.67 -37.61
2021 11.00 10.03 -4.05 -2.03 -2.94 1.54 -5.65 -4.32 -2.88 -7.66 2.58 -0.02 -6.06
2020 0.29 -10.08 -5.83 8.04 9.54 -3.43 11.43 3.27 -6.10 6.42 20.97 2.02 37.72
2019 19.30 4.88 5.08 0.05 -6.91 -4.50 -4.26 -5.75 -8.28 -1.11 0.75 -3.26 -6.72
2018 4.15 -6.00 -1.91 0.27 8.90 4.30 -5.11 23.11 12.22 -9.47 -2.01 -8.18 16.79
2017 0.00 -3.69 -1.24 -2.19 2.72 -3.23 5.15 11.62 11.93 15.90 40.81

Growth of $10,000 Invested

As at 5/29/2026 (Series A) NPP5420

Risk Tolerance

  • Low
  • Low - Med
  • Medium
  • Med - High
  • High

Facts, Fees & Fund Codes

Facts
Facts
Fund Type
Canadian Equity Income
Inception Date
Series A: 3/27/2017
Series F: 8/4/2017
Registered Tax Plan Status
Eligible
Distributions
Monthly
Performance Fee
-
Minimum Initial Investment
$500
Minimum Subsequent Investment
$25
Minimum Investment Term
20 days (1.5% penalty)
Redemptions
Daily
Valuations
Daily
Index: S&P/TSX 60 Index
††The Fund does not have a fixed distribution amount. The amount of monthly distributions may fluctuate, and there can be no assurance that the Fund will make any distribution in any particular period. The amount of ordinary cash distributions, if any, will be based on the Manager’s assessment of the prevailing market conditions. The amount of distributions may vary if there are changes in any of the factors that affect the net cash flow on the portfolio of a Fund, including the amount of leverage employed by the Fund. The amount and date of any ordinary cash distributions of the Fund will be announced in advance by issuance of a press release. Subject to compliance with the investment objectives of the Fund, the Manager may, in its complete discretion, change the frequency of these distributions and any such change will be announced by press release.
Fees
Fees
Management Fee
Series A: 1.30%
Series D: 0.30%
Series F: 0.30%
Plus the fees of the underlying funds which currently have a management fee of 0.29%
Fund Codes
Fund Codes
Series A NPP5420
Series D NPP5422
Series F NPP5421

Documents

Have a question?

Contact Us

*Capital loss carryforwards may be used to offset future realized capital gains. There is no guarantee that the Fund will realize capital gains in the future or that capital loss carryforwards will result in tax savings for investors. Tax treatment depends on an investor’s individual circumstances and may change over time.

Effective July 8, 2026 Ninepoint Cannabis & Alternative Health Fund changed its name to Ninepoint Enhanced Canadian HighShares Fund; and changed its investment strategies to invest primarily in a portfolio of exchange-traded funds that invest in single equity securities and employ covered call strategies, with the aim of providing high monthly cash distributions and the opportunity for capital appreciation. The above is the performance for the Ninepoint Cannabis & Alternative Health Fund up to July 8, 2026. All performance after July 8, 2026 is that of the Ninepoint Enhanced Canadian HighShares Fund.

All returns and fund details are a) based on Series A shares; b) net of fees; c) annualized if period is greater than one year; d) as at 5/29/2026. Where applicable, all figures are annualized and based on monthly returns since inception. The rate of return or mathematical table shown is used only to illustrate the effects of the compound growth rate and is not intended to reflect future values of the mutual fund or returns on investment in the mutual fund. Numbers may not add up due to rounding. Cash and cash equivalents include non-portfolio assets and/or liabilities.

The rate of return is used only to illustrate the effects of the compound growth rate and is not intended to reflect future values of the investment fund or returns on investment in the investment fund.

The Fund is generally exposed to the following risks: Active management risk; Concentration risk; Currency risk; Cybersecurity risk; Derivatives risk; Exchange traded funds risk;  Equity investment risk; Foreign investment risk; Fund of funds investment risk; Inflation risk;  Interest rate risk; Leverage risk; Market risk; Regulatory risk; Series risk; Specific issuer risk; Tax risk.

Ninepoint Partners LP is the investment manager to a number of funds (collectively, the “Funds”). Commissions, trailing commissions, management fees, performance fees (if any), and other expenses all may be associated with investing in the Funds. Please read the prospectus carefully before investing. The indicated rates of return for series A units of the Funds for the period ended 5/29/2026 are based on the historical annual compounded total returns including changes in unit value and reinvestment of all distributions or dividends and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated. This communication does not constitute an offer to sell or solicitation to purchase securities of the Funds.

The information contained herein does not constitute an offer or solicitation by anyone in the United States or in any other jurisdiction in which such an offer or solicitation is not authorized or to any person to whom it is unlawful to make such an offer or solicitation. Prospective investors who are not a resident in Canada should contact their financial advisor to determine whether securities of the Fund may be lawfully sold in their jurisdiction.

Ninepoint Partners LP: Toll Free: 1.866.299.9906. Dealer Services: CIBC Mellon GSSC Record Keeping Services: Toll Free: 1.877.358.0540